Incorporating Model for End-stage Liver Disease Trajectories into Liver Allocation

BACKGROUND: Liver transplant (LT) allocation prioritizes candidates by current Model for End-stage Liver Disease (MELD) score, without accounting for disease trajectory. However, the magnitude and direction of MELD change (ΔMELD) may convey additional prognostic information and could inform continuous distribution-based allocation. METHODS: We analyzed adult LT candidates in the Organ Procurement and Transplantation Network waitlist data set from January 2016 to June 2024, reformatted into a person-day structure. Discrete-time hazard models estimated associations between death or waitlist dropout at 1 and 90 d and current MELD, ΔMELD, and MELD velocity (ΔMELD/day). We derived dynamic MELD-based scores incorporating these measures (MELD-DY) and evaluated model performance using net reclassification improvement and integrated discrimination improvement. RESULTS: Among 90 622 candidates, ΔMELD was significantly associated with next-day waitlist mortality (P < 0.001), with a strong interaction between current MELD and ΔMELD (interaction odds ratio, 1.004; 95% confidence interval, 1.003-1.005), indicating that the prognostic impact of MELD change varied by MELD severity. MELD velocity was independently associated with next-day mortality (odds ratio, 1.24; confidence interval, 1.22-1.27) without requiring an interaction term. Models incorporating ΔMELD/day (dynamic MELD score based on ΔMELD/day) improved prediction of death or dropout compared with static MELD (net reclassification improvement 0.28, P < 0.001; integrated discrimination improvement >0, P < 0.001). CONCLUSIONS: MELD dynamics provide prognostic information beyond static MELD, supporting their use for real-time risk stratification and acuity-based LT allocation.

Authors

Institutions

Publication Details

Journal
Transplantation
Published
2026-06-09
DOI
https://doi.org/10.1097/tp.0000000000005771
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incorporating Model for End-stage Liver Disease Trajectories into Liver Allocation

David Axelrod, Tomohiro Tanaka, Jennifer C. Lai
Transplantation
Liver Disease and Transplantation
article

Incorporating Model for End-stage Liver Disease Trajectories into Liver Allocation

David Axelrod, Tomohiro Tanaka, Jennifer C. Lai
article en

Abstract

BACKGROUND: Liver transplant (LT) allocation prioritizes candidates by current Model for End-stage Liver Disease (MELD) score, without accounting for disease trajectory. However, the magnitude and direction of MELD change (ΔMELD) may convey additional prognostic information and could inform continuous distribution-based allocation. METHODS: We analyzed adult LT candidates in the Organ Procurement and Transplantation Network waitlist data set from January 2016 to June 2024, reformatted into a person-day structure. Discrete-time hazard models estimated associations between death or waitlist dropout at 1 and 90 d and current MELD, ΔMELD, and MELD velocity (ΔMELD/day). We derived dynamic MELD-based scores incorporating these measures (MELD-DY) and evaluated model performance using net reclassification improvement and integrated discrimination improvement. RESULTS: Among 90 622 candidates, ΔMELD was significantly associated with next-day waitlist mortality (P < 0.001), with a strong interaction between current MELD and ΔMELD (interaction odds ratio, 1.004; 95% confidence interval, 1.003-1.005), indicating that the prognostic impact of MELD change varied by MELD severity. MELD velocity was independently associated with next-day mortality (odds ratio, 1.24; confidence interval, 1.22-1.27) without requiring an interaction term. Models incorporating ΔMELD/day (dynamic MELD score based on ΔMELD/day) improved prediction of death or dropout compared with static MELD (net reclassification improvement 0.28, P < 0.001; integrated discrimination improvement >0, P < 0.001). CONCLUSIONS: MELD dynamics provide prognostic information beyond static MELD, supporting their use for real-time risk stratification and acuity-based LT allocation.

Transplantation
University of Iowa (US), University of California, San Francisco (US), University Hospitals of Cleveland (US), Orthopaedic Research Foundation (US), Medical Research Foundation (GB)
Reduced inequalities, Peace, Justice and strong institutions
Openalex Percentile: Top 7%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Incorporating Model for End-stage Liver Disease Trajectories into Liver Allocation — David Axelrod, Tomohiro Tanaka, et al. · Transplantation (2026) | TGRS Research Map | TGRS